Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M616Revenue $M114Net Margin (%)-13.4Z-Score6.4
Enterprise Value $M421EPS $-0.3Operating Margin %-10.6F-Score5
P/E(ttm))0Cash Flow Per Share $0Pre-tax Margin (%)-12.4Higher ROA y-yN
Price/Book5.010-y EBITDA Growth Rate %0Quick Ratio4.6Cash flow > EarningsY
Price/Sales6.05-y EBITDA Growth Rate %0Current Ratio4.7Lower Leverage y-yN
Price/Cash Flow0y-y EBITDA Growth Rate %-193.8ROA % (ttm)-7.6Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)-10.7Less Shares Outstanding y-yY
Payout Ratio %0Shares Outstanding M20.7ROI % (ttm)21.6Gross Margin Increase y-yY

Gurus Latest Trades with HPTX

Number of guru portfolios checked: 85. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
HPTXJoel Greenblatt 2014-12-31 Reduce$20.4 - $25.23
($22.43)
$ 29.7332%Reduce -30.66%12,557
HPTXJoel Greenblatt 2014-09-30 Buy $21.96 - $27.64
($24.83)
$ 29.7320%New holding, 18109 sh.18,109
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

HPTX is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
HPTX Joel Greenblatt 2014-12-3112,5570.060-30.66%
Premium Most recent portfolio changes are included for Premium Members only!


HPTX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Scharschmidt Bruce FrederickSVP & Chief Medical Officer 2015-02-27Sell29,800$29.89-0.54view
Nash Christine ASVP & Chief Commercial Officer 2015-01-20Sell5,000$24.8219.78view
Scharschmidt Bruce FrederickSVP & Chief Medical Officer 2014-07-02Sell200$286.18view
SANDELL SCOTT D10% Owner 2014-06-06Sell1,430$5.54436.64view
DRANT RYAN D10% Owner 2014-06-06Sell1,134$26.910.52view
BARRETT M JAMES10% Owner 2014-06-06Sell1,430$26.8810.6view
BASKETT FOREST10% Owner 2014-06-06Sell1,377$26.910.52view
BARRIS PETER J10% Owner 2014-06-06Sell1,134$26.910.52view
KOLLURI KRISHNA KITTU10% Owner 2014-06-06Sell120$27.199.34view
HEALY JAMESDirector 2014-06-04Sell417,747$27.77.33view

Press Releases about HPTX :

Quarterly/Annual Reports about HPTX:

News about HPTX:

Articles On GuruFocus.com
No related article found.


More From Other Websites
HYPERION THERAPEUTICS INC Files SEC form 10-K, Annual Report Mar 04 2015
Connecture Inc (CNXR), Hyperion Therapeutics Inc (HPTX): Top 5 Healthcare Picks of Great Point... Mar 02 2015
Hyperion Therapeutics Observes Rare Disease Day 2015 Feb 27 2015
Hyperion tops Street 4Q forecasts Feb 26 2015
Hyperion tops Street 4Q forecasts Feb 26 2015
Hyperion Therapeutics Inc Earnings Call scheduled for 4:30 pm ET today Feb 26 2015
HYPERION THERAPEUTICS INC Files SEC form 8-K, Results of Operations and Financial Condition,... Feb 26 2015
Hyperion Therapeutics Announces Fourth Quarter and Full Year 2014 Financial Results Feb 26 2015
Q4 2014 Hyperion Therapeutics Inc Earnings Release - After Market Close Feb 26 2015
Hyperion Therapeutics to Present at the Cowen and Company 35th Annual Health Care Conference Feb 25 2015
Hyperion Therapeutics to Report Fourth Quarter and Full Year 2014 Financial Results After Market on... Feb 25 2015
Should You Sell Hyperion Therapeutics (HPTX) Before Earnings? - Tale of the Tape Feb 25 2015
Will Allscripts (MDRX) Surprise Earnings Estimates in Q4? - Analyst Blog Feb 24 2015
Will DexCom (DXCM) Loss Better Estimates this Earnings? - Analyst Blog Feb 23 2015
Can Greatbatch (GB) Keep the Earnings Streak Alive in Q4? - Analyst Blog Feb 20 2015
Hyperion Therapeutics to Report Fourth Quarter and Full Year 2014 Financial Results After Market on... Feb 19 2015
Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of Hyperion Therapeutics, Inc.... Feb 18 2015
HYPERION THERAPEUTICS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial... Feb 17 2015
Hyperion Therapeutics Enters Into Completion of Phase III Clinical Trial, Option and Mutual Release... Feb 17 2015
HYPERION THERAPEUTICS INC Files SEC form 8-K, Change in Directors or Principal Officers Feb 10 2015

Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK